CompuMed, Inc.
CMPD · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $6,222 | $5,838 | $6,365 | $6,317 |
| % Growth | 6.6% | -8.3% | 0.8% | – |
| Cost of Goods Sold | $3,197 | $2,952 | $3,062 | $2,972 |
| Gross Profit | $3,025 | $2,886 | $3,304 | $3,345 |
| % Margin | 48.6% | 49.4% | 51.9% | 53% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,820 | $2,917 | $2,753 | $2,332 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,820 | $2,917 | $2,753 | $2,332 |
| Operating Income | $205 | -$31 | $550 | $1,013 |
| % Margin | 3.3% | -0.5% | 8.6% | 16% |
| Other Income/Exp. Net | -$8 | $16 | -$43 | $56 |
| Pre-Tax Income | $197 | -$15 | $507 | $1,070 |
| Tax Expense | $4 | $18 | $5 | $2 |
| Net Income | $193 | -$33 | $502 | $1,067 |
| % Margin | 3.1% | -0.6% | 7.9% | 16.9% |
| EPS | 0.15 | -0.021 | 0.3 | 0.69 |
| % Growth | 817.7% | -107% | -56.5% | – |
| EPS Diluted | 0.15 | -0.021 | 0.3 | 0.69 |
| Weighted Avg Shares Out | 1,317 | 1,558 | 1,676 | 1,537 |
| Weighted Avg Shares Out Dil | 1,317 | 1,558 | 1,676 | 1,537 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $38 | $27 | $43 | $58 |
| Depreciation & Amortization | $717 | $678 | $568 | $353 |
| EBITDA | $952 | $690 | $1,119 | $1,481 |
| % Margin | 15.3% | 11.8% | 17.6% | 23.4% |